Boston Scientific Corp. signed a $2.25 billion senior unsecured credit agreement with several lenders on Aug. 4.

Under the agreement, which refinances the company's 2015 credit facility, Boston Scientific may borrow from time to time up to $2.25 billion in revolving credit loans.

Loans under the agreement will bear interest at the company's option at either the London Interbank Offered Rate or alternate base rate plus an interest margin.

The agreement matures on Aug. 4, 2022, with one-year extension options subject to certain conditions.

Bank of America NA and Wells Fargo Bank National Association are acting as syndication agents with JPMorgan Chase Bank NA acting as administrative agent.